Transdermal and Intradermal Drug Delivery Systems, 2017



Advanced Design, Development, and Delivery of Skin-Mediated Therapies and Vaccines

The growing interest in alternative routes of drug administration has experts predicting that the market for transdermal and intradermal drug delivery systems will exceed $25 billion by 2018. The industry is on the threshold of bringing into commercial production a new generation of transformative TDD and IDD therapies and delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Featuring Representation From:

  • Pfizer
  • Merck
  • Corium
  • 3M
  • MIT
  • UCSB
  • Queens University, Belfast
  • Georgia Tech
  • Texas Tech
  • University of Mississippi
  • University of Cincinnati
  • Mercer University
  • University of Maryland
  • QPS
  • Intertek
  • Eurofins Lancaster Labs
  • ISYN Consulting
  • Zosano Pharma

With Comprehensive Coverage on:

  • Improving Bioavailability Via Transdermal Administration
  • Latest Advances in Microneedle Drug and Vaccine Delivery
  • How to Move from Passive to Active Skin-Mediated Delivery Technologies for Drugs and Biologics
  • Optimizing TDD & IDD for Efficacious Delivery and Patient Compliance
  • Mechanisms of Dermal and Transdermal Absorption of Drugs
  • Computational Modeling of Transdermal and Intradermal Delivery
  • Resolving Regulatory Compliance Issues for TDD & IDD Systems
  • IVPT and IVRT of Transdermal and Topical Products
  • Exploring the Promise of Ionic Liquids for Transdermal Applications
  • And much more!
File Type

MP4, Slide Deck


There are no reviews yet.

Be the first to review “Transdermal and Intradermal Drug Delivery Systems, 2017”

Your email address will not be published. Required fields are marked *